DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sai Life Sciences Limited — Monitoring Agency Report

NSE 3 hrs ago·7 Aug 2026, 4:42 pm

SAI Life Sciences

Sai Life Sciences has released a monitoring agency report for the quarter that ended on June 30, 2026. This report is typically an external review of the company's financial records and operational compliance. For investors, the release of such a document is a routine part of corporate governance, ensuring transparency regarding the company's performance and adherence to regulatory standards during the specified period.

The report provides an independent assessment of Sai Life Sciences' activities, which helps maintain trust with stakeholders. While the specific findings of the agency are not detailed here, the disclosure signals that the company is following standard protocols for financial reporting. Investors should monitor the report for any observations regarding operational efficiency or compliance that might impact the company's future trajectory.